Migraine
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: These included those from whom responses were received a when a self-administered web questionnaire survey on headache and QOL was conducted (from November 1, 2020 to November 30, 2020) among health insurance association members (approximately 600,000 individuals) who agreed to the secondary use of medical data and who have contracts with DeSC, and were aged 19 to less than 75 years who were registered in kencom, an app for health promotion support services provided by DeSC (approximately 150,000 individuals).
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PPV (PPV:Positive Predictive Value) | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity Specificity NPV (NPV: Negative Predictive Value) | — |
Countries
Japan
Contacts
Otsuka Pharmaceuticals Co., Ltd Medical Affairs Department